Humana’s monopolisation suit against Mallinckrodt moves forward

Humana has sufficiently alleged that Mallinckrodt illegally maintained a monopoly over treatment for infant seizures by purchasing rights to a potential substitute, a California federal court has ruled.


Get unlimited access to all Global Competition Review content